{
    "clinical_study": {
        "@rank": "62153", 
        "acronym": "OPTIC-III", 
        "arm_group": {
            "arm_group_label": "TUR-B", 
            "description": "TUR-B in patients suspected to have non-muscle-invasive bladder cancer (NMIBC)."
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to assess additional detection of Non-Muscle-Invasive Bladder\n      Cancer (NMIBC) with hexyl aminolevulinate (HAL) cystoscopy based on lesions in patients\n      undergoing TUR-B compared to white-light cystoscopy under the conditions of daily clinical\n      practice."
        }, 
        "brief_title": "Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Photodynamic Transurethral Resection of the Bladder (TUR-B)", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Indication of TURB due to suspicion of NMIBC (patients suspected to have non muscle\n             invasive bladder cancer).\n\n          -  Subject able to comply with the protocol.\n\n          -  Written informed consent available.\n\n        Exclusion Criteria:\n\n          -  Hypersensitivity to the active substance or to any of the excipients of the solvent.\n\n          -  Porphyria.\n\n          -  Gross haematuria.\n\n          -  Women of child-bearing potential.\n\n          -  Repeated TURB (control TURB) as part of follow-up after previous TURB.\n\n          -  Bacillus Calmette-Guerin (BCG) or Mitomycin / intravesical chemotherapy instillation\n             therapy in the last 12 weeks or any other contraindications according to the SmPC.\n\n          -  Subjects not able to give informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Bladder cancer patients"
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02012036", 
            "org_study_id": "A-94-58150-002"
        }, 
        "intervention": {
            "arm_group_label": "TUR-B", 
            "description": "As this is a non-interventional study, detection of NMIBC with Hexvix is in a pre-defined group, chosen prior to and independently from the decision to enrol the subject in this study.\nThe detection with Hexvix should be in accordance with local Summary of Product Characteristics [SmPC].\nSubjects will be treated in accordance with usual medical practice during their participation in this study, no additional assessment or tests will be required.", 
            "intervention_name": "Hexvix", 
            "intervention_type": "Drug", 
            "other_name": "hexyl aminolevulinate (HAL)"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 29, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "zip": "93059"
                    }, 
                    "name": "Caritas-Krankenhaus St. Josef, Klinik fuer Urologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sindelfingen", 
                        "country": "Germany", 
                        "zip": "71065"
                    }, 
                    "name": "Klinikverbund S\u00fcdwest"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Non-Interventional Study To Optimize Photodynamic TUR-B In Clinical Practice", 
        "overall_official": {
            "affiliation": "Ipsen", 
            "last_name": "Bryan Qvick, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Detection rate is defined as number of lesions detected or not (Detection by HAL cystoscopy compared to white light cystoscopy confirmed by histology).", 
            "measure": "Detection rate", 
            "safety_issue": "No", 
            "time_frame": "At TUR-B visit, up to 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02012036"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Risk groups are low, intermediate and high.", 
                "measure": "Detection rate for risk groups according to the European Organisation for Research and Treatment of Cancer (EORTC)-score", 
                "safety_issue": "No", 
                "time_frame": "At TUR-B visit, up to 1 year"
            }, 
            {
                "measure": "Evaluation of the diagnostic procedure in practice and compared to procedures according to published recommendations", 
                "safety_issue": "No", 
                "time_frame": "At TUR-B visit, up to 1 year"
            }
        ], 
        "source": "Ipsen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ipsen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}